New spinal injection tested for ALS patients
NCT ID NCT06493279
Summary
This early-stage study is testing the safety of a single spinal injection called RJK002 in people with ALS. The trial involves 9 participants who were diagnosed within the last 2 years and still have good breathing and movement function. Researchers will monitor for side effects and see if the treatment helps slow the decline in daily activities over 9 months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.